George Soros's FOLD Position Overview
George Soros (via Soros Fund Management LLC) currently holds 5 M shares of Amicus Therapeutics, Inc. (FOLD) worth $71.2 M, representing 0.82% of the portfolio. First purchased in 2014-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, George Soros has maintained this position in FOLD for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 5 M shares. Largest reduction occurred in Q3 2014, reducing 70,500 shares.
Analysis based on 13F filings available since 2013 Q2
George Soros's Amicus Therapeutics (FOLD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amicus Therapeutics (FOLD) Trades by George Soros
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +70,500 | New Buy | 70,500 | $3.33 |
| Q3 2014 | -70,500 | Sold Out | 0 | $0.00 |
| Q4 2025 | +5 M | New Buy | 5 M | $14.24 |
George Soros's Amicus Therapeutics Investment FAQs
George Soros first purchased Amicus Therapeutics, Inc. (FOLD) in Q2 2014, acquiring 70,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
George Soros has held Amicus Therapeutics, Inc. (FOLD) for 3 quarters since Q2 2014.
George Soros's largest addition to Amicus Therapeutics, Inc. (FOLD) was in Q4 2025, adding 5,000,000 shares worth $71.2 M.
According to the latest 13F filing for Q4 2025, George Soros's firm, Soros Fund Management LLC, owns 5,000,000 shares of Amicus Therapeutics, Inc. (FOLD), valued at approximately $71.2 M.
As of the Q4 2025 filing, Amicus Therapeutics, Inc. (FOLD) represents approximately 0.82% of George Soros's publicly disclosed stock portfolio, making it one of their key holdings.
George Soros's peak holding in Amicus Therapeutics, Inc. (FOLD) was 5,000,000 shares, as reported at the end of Q4 2025.